ZAP70 and B-cell chronic lymphocytic leukemia: In an early study of 107 CLL patients, in 93% of patients the ZAP70 expression level was 5.54-fold higher in patients with unmutated IGHV than in patients with mutated IGHV, and thus, ZAP-70 was suggested to be a prognostic indicator in CLL [42].